Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine whether administrating of Amantadine (a dopamine agonist) to patients suffering from Parkinson disease during the perioperative period is safe, and to asses potential benefits of this treatment.
Age
All ages
Sex
ALL
Healthy Volunteers
No
Rabin Medical Center
Petah Tikva, Israel
Start Date
January 1, 2008
Primary Completion Date
July 1, 2011
Completion Date
July 1, 2011
Last Updated
July 26, 2011
20
ESTIMATED participants
Amantadine
DRUG
Lead Sponsor
Rabin Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06113640